Vistin Pharma has a long lasting experience and expertise in manufacturing solid dosage forms, both for captive use (as Weifa) and as a contract manufacturer (CMO) to reputable international pharmaceutical companies. As a result of our business strategy, our production site in Kragerø, Norway has during recent years been transformed to an efficient, dedicated tablet manufacturing plant.
Going forward, Vistin Pharma will continue focusing on and expanding its CMO business. Through our competencies, product offerings, customer service and international relationships, we aim to attract new customers and tablet volumes.
Our 2015 production volume is ~650 million tablets, which can easily be expanded up to ~950 million tablets annually within current installed capacity.